Long
LONG $ARDM (Aradigm) heading into 2 BIG Catalysts - HEADING UP ?
ARDM SHOULD BE HEADING UP INTO 2 BIG Catalysts - HEADING UP TO $8 1- ADCOM DAY ON JAN 11 2018
2- PDUFA date - priority review January 26, 2018. Phase 3 data released December 1, 2016.
Drug: Linhaliq (Pulmaquin) for Non-cystic fibrosis bronchiectasis (non-CF BE).
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.